Employment and Work Ability of Persons With Brain Tumors: A Systematic Review

Frontiers in Human Neuroscience
Fabiola SilvaggiSilvia Schiavolin

Abstract

Brain tumors (BT) are between the eight most common cancers among persons aged 40 years, with an average survival time of 10 years for patients affected by non-malignant brain tumor. Some patients continue to work, reporting difficulties in work-related activities, or even job loss. The purpose of the present study was to review the existing information about the ability people with BT to return to work and to identify factors associated with job loss. We performed a systematic review on SCOPUS and EMBASE for peer-reviewed papers that reported studies assessing work ability in patients with BT that were published in the period from January 2010 to January 2020. Out of 800 identified records, 7 articles were selected for analysis, in which 1,507 participants with BT were enrolled overall. Three main themes emerged: the impact of neuropsychological functioning on work productivity, the change of employment status for long-term survivors and issues related to return to work processes. Based on the results of selected studies, it can be concluded that the impact of BT on workforce participation is determined by depressive symptoms and cognitive deficits, as well as by high short-term mortality but also on environmental barriers. Vo...Continue Reading

References

Dec 1, 1990·Annals of Neurology·J P ImperatoN A Vick
Apr 30, 1993·International Journal of Radiation Oncology, Biology, Physics·L KleinbergM G Malkin
Aug 17, 1999·Journal of Neurology, Neurosurgery, and Psychiatry·A R Giovagnoli
Dec 6, 2001·The Journal of Head Trauma Rehabilitation·J D CorriganL Fugate
Mar 29, 2002·Psycho-oncology·Evelien R SpeltenJos H A M Verbeek
Jul 9, 2002·General Hospital Psychiatry·John W WilliamsChristina Perez Stellato
Jul 12, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E R SpeltenM A G Sprangers
Jan 28, 2004·Neurosurgery·N Scott LitofskyUNKNOWN Glioma Outcomes Project Investigators
Sep 2, 2004·Journal of the National Cancer Institute·K Robin YabroffMartin L Brown
Feb 9, 2005·Cancer·Pamela Farley ShortKaan Tunceli
Jan 10, 2006·Cancer·Julienne E BowerThomas R Belin
Mar 23, 2006·Occupational and Environmental Medicine·W Eriksen
Apr 28, 2006·Current Opinion in Psychiatry·Frank J Penedo, Jason R Dahn
May 15, 2007·Acta Oncologica·T Taskila, M L Lindbohm
Jul 12, 2007·Journal of Occupational and Environmental Medicine·Michael FeuersteinJonne G Ronquillo
Oct 11, 2007·Journal of Neuro-oncology·Denise D CorreaLauren E Abrey
May 30, 2008·Journal of Rehabilitation Medicine·Anna Häggström, Maria Larsson Lund
Sep 19, 2008·Cancer·Melissa L BondyUNKNOWN Brain Tumor Epidemiology Consortium
Oct 17, 2008·Developmental Disabilities Research Reviews·Shawna L Palmer
Mar 12, 2009·Scandinavian Journal of Work, Environment & Health·Jussi Ilmarinen
Sep 24, 2013·Journal of Neurology, Neurosurgery, and Psychiatry·Abdul Rahman Al-ShudifatPeter Siesjo
Nov 26, 2013·Journal of Occupational and Environmental Medicine·Courtney CollinsMichael Feuerstein
Mar 13, 2014·Journal of Internal Medicine·R C PetersenL Fratiglioni
Aug 12, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Antonio OmuroJason T Huse
Aug 13, 2014·Nature Reviews. Clinical Oncology·Julienne E Bower
Mar 13, 2015·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·C LucchiariG Pravettoni
Mar 15, 2015·CNS Oncology·Aiste Pranckeviciene, Adomas Bunevicius
Mar 20, 2015·Neuro-oncology Practice·Bethany D NugentPaula R Sherwood
Mar 21, 2015·European Journal of Endocrinology·Sarah M LeistnerCaroline Sievers
Sep 1, 2015·Journal of Cancer Survivorship : Research and Practice·Motoki EndoNaohito Yamaguchi
Mar 18, 2016·CNS Oncology·Arash AsherJennifer K Hughes
Dec 31, 2016·Work : a Journal of Prevention, Assessment, and Rehabilitation·Marie MatérneThomas Strandberg
Apr 26, 2017·American Journal of Physical Medicine & Rehabilitation·Stacy McCartyAlex W K Wong
Oct 25, 2017·Ecancermedicalscience·Cristiane H GallaschPatricia Cp Baptista
Jun 2, 2018·Neurosurgical Focus·Daniele StarnoniJacques Guyotat

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
J M Scriber
Environmental Health Perspectives
Nature Biotechnology
W H McGaugheyW Gelernter
Nature Immunology
Zoltan Fehervari
© 2021 Meta ULC. All rights reserved